- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 2 x P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL(Non-covalent)
P15.3: 15 residues within 4Å:- Chain A: L.128, T.132, R.135, L.139, M.210, G.340, T.343, L.344, V.347, L.348, F.351, N.384, N.388, I.391, Y.392
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.135, A:R.135, A:N.384, A:N.384, A:Y.392
P15.5: 2 residues within 4Å:- Chain A: Q.400, W.404
No protein-ligand interaction detected (PLIP)- 12 x OLA: OLEIC ACID(Non-covalent)
OLA.4: 5 residues within 4Å:- Chain A: A.197, A.201, F.204, F.207, V.363
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.197, A:F.207, A:V.363
OLA.6: 4 residues within 4Å:- Chain A: L.170, L.174, G.175
- Ligands: OLA.7
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.170, A:L.174, A:L.174
OLA.7: 3 residues within 4Å:- Chain A: G.175, W.176
- Ligands: OLA.6
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.176, A:W.176, A:W.176
- Water bridges: A:N.177, A:S.194
OLA.8: 9 residues within 4Å:- Chain A: V.63, A.67, R.73, T.85, L.92, L.96, F.116
- Ligands: OLA.17, CLR.20
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.63, A:A.67, A:T.85, A:L.92, A:F.116
- Salt bridges: A:R.73
OLA.9: 6 residues within 4Å:- Chain A: N.42, P.43, W.44, L.47, V.372
- Ligands: OLA.18
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:P.43, A:W.44, A:W.44, A:L.47
- Hydrogen bonds: A:N.42
OLA.10: 16 residues within 4Å:- Chain A: H.97, L.117, V.187, V.188, R.189, V.196, L.199, S.200, W.355, F.358, C.362, A.371, T.374, Y.375, L.378
- Ligands: OLA.13
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.117, A:V.188, A:V.196, A:L.199, A:W.355, A:F.358, A:T.374, A:Y.375
- Hydrogen bonds: A:R.189
- Water bridges: A:R.189
OLA.13: 9 residues within 4Å:- Chain A: A.122, V.125, S.126, T.161, V.164, A.202, F.203
- Ligands: OLC.2, OLA.10
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.125, A:T.161, A:V.164, A:A.202, A:F.203
OLA.15: 5 residues within 4Å:- Chain A: Y.136, I.209, H.212, R.216
- Ligands: OLC.2
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.209
- Hydrogen bonds: A:Y.136
- Salt bridges: A:H.212, A:R.216
OLA.16: 6 residues within 4Å:- Chain A: L.156, A.159, A.160, T.163, V.164
- Ligands: OLC.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.156, A:A.159, A:T.163, A:V.164
OLA.17: 6 residues within 4Å:- Chain A: L.92, L.96, F.100, V.104
- Ligands: OLA.8, OLC.12
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.92, A:L.96, A:F.100, A:V.104
OLA.18: 4 residues within 4Å:- Chain A: P.43, L.47, V.50
- Ligands: OLA.9
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:P.43, A:L.47, A:V.50
OLA.19: 4 residues within 4Å:- Chain A: L.61, L.406, L.407
- Ligands: OLC.14
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.406, A:L.406
- 1 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Barekatain, M. et al., Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's disease. Sci.Signal. (2024)
- Release Date
- 2024-12-04
- Peptides
- G-protein coupled receptor 6,Soluble cytochrome b562 chimera,Soluble cytochrome b562,G-protein coupled receptor 6: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- monomer
- Ligands
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 2 x P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL(Non-covalent)
- 12 x OLA: OLEIC ACID(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Barekatain, M. et al., Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's disease. Sci.Signal. (2024)
- Release Date
- 2024-12-04
- Peptides
- G-protein coupled receptor 6,Soluble cytochrome b562 chimera,Soluble cytochrome b562,G-protein coupled receptor 6: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.